Avanos Medical, Inc.AVNSNYSE
LOADING
|||
Revenue Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
1.60%
↑ 274% above average
Average (39q)
-0.92%
Historical baseline
Range
High:13.44%
Low:-62.31%
CAGR
-1.6%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 1.60% |
| Q2 2025 | 4.48% |
| Q1 2025 | -6.74% |
| Q4 2024 | 5.40% |
| Q3 2024 | -0.76% |
| Q2 2024 | 3.37% |
| Q1 2024 | -4.15% |
| Q4 2023 | 1.17% |
| Q3 2023 | 1.12% |
| Q2 2023 | 6.34% |
| Q1 2023 | -12.28% |
| Q4 2022 | 5.40% |
| Q3 2022 | 0.82% |
| Q2 2022 | -13.42% |
| Q1 2022 | 2.07% |
| Q4 2021 | 5.05% |
| Q3 2021 | -1.23% |
| Q2 2021 | 3.15% |
| Q1 2021 | -2.32% |
| Q4 2020 | -0.38% |
| Q3 2020 | 13.44% |
| Q2 2020 | -9.26% |
| Q1 2020 | -4.95% |
| Q4 2019 | 10.74% |
| Q3 2019 | -0.46% |
| Q2 2019 | 4.87% |
| Q1 2019 | -3.35% |
| Q4 2018 | 2.91% |
| Q3 2018 | 2.61% |
| Q2 2018 | 2.88% |
| Q1 2018 | -5.95% |
| Q4 2017 | 10.50% |
| Q3 2017 | 0.94% |
| Q2 2017 | -62.31% |
| Q1 2017 | -3.51% |
| Q4 2016 | 3.14% |
| Q3 2016 | -0.63% |
| Q2 2016 | 3.95% |
| Q1 2016 | -4.14% |
| Q4 2015 | 3.06% |